-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
U.
The U.
This is the first targeted therapy for tumors with KRAS mutations
Dr.
Amgen said that Lumakras, also known as sotorasib, will cost $17,900 per month, but according to medical insurance and other factors, most patients' costs will be reduced
The agency also approved diagnostic tests from two companies to determine whether patients have this particular mutation, KRAS G12C
Common side effects include diarrhea, joint and muscle pain, fatigue, and liver damage